EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Remote Patient Monitoring in Heart Failure

Mohammad Abu Zalam

Global Cardiology Science and Practice · 22.05.2026 · 2026 (S2)

DOI: 10.21542/gcsp.2026.s2.76 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global Cardiology Science and Practice, online erschienen am 22.05.2026. Verfasst von Mohammad Abu Zalam. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart failure (HF) remains a major public health burden, accounting for approximately one million hospitalizations annually in the United States, with nearly 20% of patients readmitted within 30 days. Remote patient monitoring (RPM), using connected devices and telehealth platforms, has emerged as a promising approach to detect early signs of decompensation, improve adherence to guideline-directed therapy, and reduce recurrent hospitalizations. Recent large-scale trials and real-world studies have evaluated RPM’s effects on clinical outcomes, patient-reported quality of life, and mortality.

Methods

We reviewed recent data from randomized and real-world studies examining the impact of RPM on HF management. The MONITOR-HF trial (Lancet 2023) enrolled approximately 340 patients with NYHA class III HF, comparing implantable pulmonary-artery pressure–guided management with usual care. The E-INH trial (JACC HF 2023) evaluated a nurse-coordinated, telephone-based RPM program in 1,022 post-discharge patients with reduced ejection fraction, extending follow-up to ten years. Additionally, a prospective ACO cohort (2021–2022) implemented a short-term home RPM program using daily vital sign and symptom tracking in high-risk HF patients after discharge.

Results

In MONITOR-HF, RPM significantly reduced HF events compared with standard care (hazard ratio [HR] 0.56; p=0.0053) and improved health-related quality of life, reflected by a mean 12-month KCCQ improvement of seven points versus controls. E-INH found no early reduction in death or hospitalization but demonstrated lower all-cause mortality at five and ten years (HR 0.82 and 0.83, respectively). The ACO registry showed a non-significant reduction in 6-month readmissions yet revealed markedly lower short-term mortality (6.4% vs 17%). Across studies, adherence to monitoring varied, with engagement declining over time, emphasizing the need for structured support strategies.

Conclusion

Collectively, evidence supports RPM as an effective adjunct to guideline-based HF management, improving quality of life, reducing hospitalizations, and potentially lowering long-term mortality when sustained adherence is achieved.

Zitieren

APA

Zalam, M. A. (2026). Remote Patient Monitoring in Heart Failure. Global Cardiology Science and Practice, 2026(S2). https://doi.org/10.21542/gcsp.2026.s2.76

Vancouver

Zalam MA. Remote Patient Monitoring in Heart Failure. Global Cardiology Science and Practice. 2026;2026(S2). doi:10.21542/gcsp.2026.s2.76

BibTeX
@article{Zalam2026,
  author = {Zalam, Mohammad Abu},
  title = {Remote Patient Monitoring in Heart Failure},
  journal = {Global Cardiology Science and Practice},
  year = {2026},
  volume = {2026},
  number = {S2},
  doi = {10.21542/gcsp.2026.s2.76}
}
Kostenlos starten →